drugset / Trial / NCT05508815

Modified Zhiwang Decoction Combined With Methotrexate in the Treatment of Early Rheumatoid Arthritis

NCT05508815

Phase 0 Unknown 150 enrolled Beijing University of Chinese Medicine
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to evaluate the effectiveness and safety of Modified Zhiwang Decoction in combination with methotrexate for the treatment of early RA patients and a parallel-group, single-center randomized controlled clinical study was designed.

Timeline

Start
2023-02-09
Primary completion
2024-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Modified Zhiwang Decoction Unknown 100 ml
Comparator Methotrexate Small molecule 7.5 mg
Comparator Methotrexate Small molecule 15 mg

Indications